| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |